The role of progesterone in menstrual migraine

Neurology ◽  
1971 ◽  
Vol 21 (8) ◽  
pp. 853-853 ◽  
Author(s):  
B. W. Somerville
Keyword(s):  
Menstrual Migraine

Headache

2017 ◽  
Author(s):  
Regina Krel ◽  
Paul G. Mathew
Keyword(s):  
Menstrual Cycle ◽  
Chief Complaint ◽  
Menstrual Migraine ◽  
Clinical Implications ◽  
Menstrually Related Migraine ◽  
Neurology Clinic ◽  
Gender Specific ◽  
Insight Into ◽  
Pure Menstrual Migraine

Migraine is a common disorder that affects women of menstruating age, and it is frequently the chief complaint of women presenting in the neurology clinic. The prevalence of menstrually related migraine can range from 20–60%, while pure menstrual migraine occurs in less than 10% of women. In addition to utilizing non–gender-specific abortive and preventative strategies, understanding migraine and its relationship to hormones, particularly estrogen, can have clinical implications for optimal treatment. This chapter seeks to provide insight into diagnosing menstrually related migraine, the role of decreased estrogen just prior to menstrual cycle onset and migraine, as well as the therapeutic options that are available to treat and possibly prevent menstrual migraine attacks.

The role of estradiol withdrawal in the etiology of menstrual migraine

Neurology ◽  
1972 ◽  
Vol 22 (4) ◽  
pp. 355-355 ◽  
Author(s):  
B. W. Somerville
Keyword(s):  
Menstrual Migraine

Menstrual Migraine in A Representative Dutch Population Sample: Prevalence, Disability and Treatment

Cephalalgia ◽  
2003 ◽  
Vol 23 (4) ◽  
pp. 302-308 ◽  
Author(s):  
EGM Couturier ◽  
MAM Bomhof ◽  
A Knuistingh Neven ◽  
NP van Duijn
Keyword(s):  
Oral Contraceptives ◽  
Potential Role ◽  
Population Sample ◽  
Population Based ◽  
Menstrual Migraine ◽  
Substantial Proportion ◽  
Daily Activities ◽  
Dutch Population ◽  
Frequent Problem

We assessed the prevalence of menstrual migraine and its restrictions on daily activities in a representative Dutch population sample of 1181 Dutch women, aged 13-55 years. Further, we evaluated the potential role of oral contraceptives, and how menstrual migraine is treated. More than half suffered from menstrual complaints, a substantial proportion reported headache or migraine as a frequent problem. Use of oral contraceptives seemed to reduce the occurrence of menstrual complaints, but not the occurrence of headache and migraine. In our study, the prevalence of menstrual migraine (3%) is lower than in the literature, most probably because we did not use a selected group of patients but a population-based sample of ordinary women. It was confirmed that attacks of menstrual migraine are more severe, of longer duration, and more resistant to treatment than migraine attacks at other times of the month.

scholarly journals Role of acetazolamide in treatment of patients with menstrual migraine

2021 ◽  
Vol 26 (4) ◽  
pp. 751-759
Author(s):  
Güldeniz Çetin ◽  
Aysin Kisabay Ak ◽  
Beyhan Cengiz Özyurt ◽  
Deniz Selçuki
Keyword(s):  
Quality Of Life ◽  
Post Treatment ◽  
Menstrual Migraine ◽  
Short Term ◽  
Significant Difference ◽  
Before And After ◽  
Headache Impact ◽  
Short Term Prophylaxis

Objective: According to the ICHD-3 criteria, menstrual migraine (MM) is divided into two groups: pure menstrual migraine (PMM) and menstrually-related migraine (MRM). The present study aimed to evaluate and compare the severity of headache using a visual analog scale (VAS) and the effect on quality of life using the Headache Impact Test (HIT) and Migraine Disability Assessment (MIDAS) tests before and after 3 months of treatment in using short-term prophylaxis with acetazolamide. Methods: Patients who presented to the headache outpatient clinic of the neurology department with a diagnosis of MM were retrospectively reviewed. Acetazolamide was given at a dosage of 500 mg daily for 5 days starting two days before the predicted onset of the menstrual cycle as a short-term prophylactic treatment. VAS, MIDAS, and HIT assessments were performed before and after treatment. Results: A total of 26 patients with PMM and 26 patients with MRM were identified. After acetazolamide treatment, statistically significant improvement was found in MIDAS, VAS and HIT scores in both groups of patients. The post-treatment MIDAS score was significantly lower in the MRM group, but there was no significant difference in post-treatment VAS and HIT scores between the groups. Conclusion: Using acetazolamide for short-term prophylaxis in patients with MM leads to decreased severity and frequency of headache and improvement in quality of life. The study is the first in the literature to use acetazolamide for short-term prophylaxis in patients diagnosed with MM.

Pathophysiological aspects of menstrual migraine

Cephalalgia ◽  
1997 ◽  
Vol 17 (20_suppl) ◽  
pp. 32-34 ◽  
Author(s):  
C Benedetto ◽  
G Allais ◽  
D Ciochetto ◽  
C De Lorenzo
Keyword(s):  
Platelet Function ◽  
Plasma Concentrations ◽  
Ovarian Hormones ◽  
Menstrual Migraine ◽  
Platelet Activity ◽  
Endogenous Opioid ◽  
Peripheral Plasma ◽  
Migraine Pathogenesis ◽  
Acid Metabolites

We review the role of several biochemical and hormonal factors in menstrual migraine pathogenesis: ovarian hormones, aldosterone circadian rhythm, nocturnal urinary melatonin excretion, sympathetic autonomic system, prolactin levels and dopaminergic function, endogenous opioid tonus, platelet activity and arachidonic acid metabolites. In particular, we focus on certain aspects of platelet function and prostaglandin metabolism, taking into consideration the different behavior of platelet sensitivity to prostacyclin, intraplatelet 5HT, peripheral plasma concentrations of 6-keto-PGF1α and PGE2 in menstrual migraine sufferers and in control subjects during the menstrual cycle. A comprehensive view of the data suggests that a complex impairment of PG and 5HT metabolism, and of platelet function, may play a significant role in the pathogenesis of menstrual migraine. However, it is not yet clear whether these alterations are primary or secondary to neuroendocrine disorders.

Role of dactinomycin in the improved survival of children with Wilms' tumor

JAMA ◽  
1966 ◽  
Vol 195 (12) ◽  
pp. 1005-1009 ◽  
Author(s):  
D. J. Fernbach
Keyword(s):  
Wilms Tumor

Role of the allergist in diagnosis and management of patients with uveitis

JAMA ◽  
1966 ◽  
Vol 195 (3) ◽  
pp. 167-172 ◽  
Author(s):  
T. E. Van Metre
Keyword(s):  
Diagnosis And Management

The power of norms to sway fused group members

2018 ◽  
Vol 41 ◽  
Author(s):  
Winnifred R. Louis ◽  
Craig McGarty ◽  
Emma F. Thomas ◽  
Catherine E. Amiot ◽  
Fathali M. Moghaddam
Keyword(s):  
Evolutionary Anthropology ◽  
Normative Systems ◽  
Violent Extremism ◽  
Identity Fusion ◽  
Group Members

AbstractWhitehouse adapts insights from evolutionary anthropology to interpret extreme self-sacrifice through the concept of identity fusion. The model neglects the role of normative systems in shaping behaviors, especially in relation to violent extremism. In peaceful groups, increasing fusion will actually decrease extremism. Groups collectively appraise threats and opportunities, actively debate action options, and rarely choose violence toward self or others.

Elaborating the role of reflection and individual differences in the study of folk-economic beliefs

2018 ◽  
Vol 41 ◽  
Author(s):  
Kevin Arceneaux
Keyword(s):  
Decision Making ◽  
Individual Differences ◽  
Cognitive Processes ◽  
Evolutionary History ◽  
Behavioral Responses ◽  
History Of ◽  
Economic Beliefs

AbstractIntuitions guide decision-making, and looking to the evolutionary history of humans illuminates why some behavioral responses are more intuitive than others. Yet a place remains for cognitive processes to second-guess intuitive responses – that is, to be reflective – and individual differences abound in automatic, intuitive processing as well.

Sign in / Sign up

Export Citation Format

Share Document